Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and ... costs for ...

The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday.

Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed a "shocking first miss" during its most recent ...

An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11, 2023. [Photo: Brendan ...

New, popular injectable weight loss drugs — GLP-1 drugs — are ... up from $125 million in 2022. Already in 2022, GLP-1 drugs accounted for 5 percent of pharmacy spending among people with ...

Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in ... [+] five large employers are covering such prescriptions, a new KFF analysis shows. In this ...